These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10484796

  • 1. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis.
    Ravelli A, Viola S, Migliavacca D, Ruperto N, Pistorio A, Martini A.
    J Pediatr; 1999 Sep; 135(3):316-20. PubMed ID: 10484796
    [Abstract] [Full Text] [Related]

  • 2. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED, Sönmez HE, Gülhan B, Arıcı ZS, Topaloğlu R, Bilginer Y.
    Turk J Pediatr; 2017 Sep; 59(1):6-12. PubMed ID: 29168357
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.
    Raab A, Kallinich T, Huscher D, Foeldvari I, Weller-Heinemann F, Dressler F, Kuemmerle-Deschner JB, Klein A, Horneff G.
    Pediatr Rheumatol Online J; 2021 Mar 22; 19(1):41. PubMed ID: 33752685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
    Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier G, Verazza S, Giancane G, Consolaro A, Ravelli A.
    Pediatr Rheumatol Online J; 2019 Jul 25; 17(1):50. PubMed ID: 31345226
    [Abstract] [Full Text] [Related]

  • 11. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
    Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ, Childhood Arthritis and Rheumatology Research Alliance (CARRA).
    J Rheumatol; 2014 Jun 25; 41(6):1163-70. PubMed ID: 24786928
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.
    Lin YT, Tsai MJ, Wang LH, Huang MT, Yang YH, Chiang BL.
    J Formos Med Assoc; 2000 Aug 25; 99(8):623-9. PubMed ID: 10969505
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J, Fingerhutová Š, Kobrová K, Srp R, Němcová D, Hoza J, Uher M, Saifridová M, Linková L, Doležalová P.
    Pediatr Rheumatol Online J; 2016 Jun 14; 14(1):36. PubMed ID: 27301536
    [Abstract] [Full Text] [Related]

  • 16. Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes.
    Su Y, Yang YH, Chiang BL.
    Clin Rheumatol; 2017 Sep 14; 36(9):1997-2004. PubMed ID: 28540607
    [Abstract] [Full Text] [Related]

  • 17. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
    van Dijkhuizen EH, Wulffraat NM.
    Pediatr Rheumatol Online J; 2014 Sep 14; 12():51. PubMed ID: 25525416
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
    Zajc Avramovič M, Dolžan V, Toplak N, Accetto M, Lusa L, Avčin T.
    J Rheumatol; 2017 Aug 14; 44(8):1216-1223. PubMed ID: 28572465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.